Cargando…
Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
Colorectal cancer (CRC) is a worldwide health concern which requires efficient therapeutic strategies. The mechanisms underlying CRC remain an essential subject of investigations in the cancer biology field. The evaluation of human microbiota can be critical in this regard, since the disruption of t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920974/ https://www.ncbi.nlm.nih.gov/pubmed/31766208 http://dx.doi.org/10.3390/microorganisms7110561 |
_version_ | 1783481056638271488 |
---|---|
author | Tarashi, Samira Siadat, Seyed Davar Ahmadi Badi, Sara Zali, Mohammadreza Biassoni, Roberto Ponzoni, Mirco Moshiri, Arfa |
author_facet | Tarashi, Samira Siadat, Seyed Davar Ahmadi Badi, Sara Zali, Mohammadreza Biassoni, Roberto Ponzoni, Mirco Moshiri, Arfa |
author_sort | Tarashi, Samira |
collection | PubMed |
description | Colorectal cancer (CRC) is a worldwide health concern which requires efficient therapeutic strategies. The mechanisms underlying CRC remain an essential subject of investigations in the cancer biology field. The evaluation of human microbiota can be critical in this regard, since the disruption of the normal community of gut bacteria is an important issue in the development of CRC. However, several studies have already evaluated the different aspects of the association between microbiota and CRC. The current study aimed at reviewing and summarizing most of the studies on the modifications of gut bacteria detected in stool and tissue samples of CRC cases. In addition, the importance of metabolites derived from gut bacteria, their relationship with the microbiota, and epigenetic modifications have been evaluated. |
format | Online Article Text |
id | pubmed-6920974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69209742019-12-24 Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? Tarashi, Samira Siadat, Seyed Davar Ahmadi Badi, Sara Zali, Mohammadreza Biassoni, Roberto Ponzoni, Mirco Moshiri, Arfa Microorganisms Review Colorectal cancer (CRC) is a worldwide health concern which requires efficient therapeutic strategies. The mechanisms underlying CRC remain an essential subject of investigations in the cancer biology field. The evaluation of human microbiota can be critical in this regard, since the disruption of the normal community of gut bacteria is an important issue in the development of CRC. However, several studies have already evaluated the different aspects of the association between microbiota and CRC. The current study aimed at reviewing and summarizing most of the studies on the modifications of gut bacteria detected in stool and tissue samples of CRC cases. In addition, the importance of metabolites derived from gut bacteria, their relationship with the microbiota, and epigenetic modifications have been evaluated. MDPI 2019-11-13 /pmc/articles/PMC6920974/ /pubmed/31766208 http://dx.doi.org/10.3390/microorganisms7110561 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tarashi, Samira Siadat, Seyed Davar Ahmadi Badi, Sara Zali, Mohammadreza Biassoni, Roberto Ponzoni, Mirco Moshiri, Arfa Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? |
title | Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? |
title_full | Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? |
title_fullStr | Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? |
title_full_unstemmed | Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? |
title_short | Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer? |
title_sort | gut bacteria and their metabolites: which one is the defendant for colorectal cancer? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920974/ https://www.ncbi.nlm.nih.gov/pubmed/31766208 http://dx.doi.org/10.3390/microorganisms7110561 |
work_keys_str_mv | AT tarashisamira gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer AT siadatseyeddavar gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer AT ahmadibadisara gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer AT zalimohammadreza gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer AT biassoniroberto gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer AT ponzonimirco gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer AT moshiriarfa gutbacteriaandtheirmetaboliteswhichoneisthedefendantforcolorectalcancer |